Quality Assurance teams play a critical role in advanced therapy manufacturing, but manual document review can consume significant time and resources.

In one AAV manufacturing process, autoloMATE® reduced the QA effort required for end-to-end document review by 65% compared with traditional paper-based operations.

Reducing the administrative burden on QA teams allows them to focus on higher-value activities while helping accelerate review and product release.

🔗 Read the whitepaper to see the full findings from our real-world study with the Cell and Gene Therapy Catapult. Learn more via this link.